JP2025504247A5 - - Google Patents
Info
- Publication number
- JP2025504247A5 JP2025504247A5 JP2024547665A JP2024547665A JP2025504247A5 JP 2025504247 A5 JP2025504247 A5 JP 2025504247A5 JP 2024547665 A JP2024547665 A JP 2024547665A JP 2024547665 A JP2024547665 A JP 2024547665A JP 2025504247 A5 JP2025504247 A5 JP 2025504247A5
- Authority
- JP
- Japan
- Prior art keywords
- liquid formulation
- present
- formulation according
- here
- botulinum toxin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22156850 | 2022-02-15 | ||
| EP22156850.4 | 2022-02-15 | ||
| PCT/EP2023/053634 WO2023156385A1 (en) | 2022-02-15 | 2023-02-14 | Liquid botulinum toxin formulation and use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025504247A JP2025504247A (ja) | 2025-02-06 |
| JP2025504247A5 true JP2025504247A5 (https=) | 2026-01-20 |
Family
ID=80682748
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024547665A Pending JP2025504247A (ja) | 2022-02-15 | 2023-02-14 | 液体ボツリヌス毒素製剤及びその使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20250161186A1 (https=) |
| EP (1) | EP4479012A1 (https=) |
| JP (1) | JP2025504247A (https=) |
| KR (1) | KR20240150786A (https=) |
| CN (1) | CN118829442A (https=) |
| AR (1) | AR128515A1 (https=) |
| AU (1) | AU2023222384A1 (https=) |
| CA (1) | CA3243198A1 (https=) |
| CO (1) | CO2024010938A2 (https=) |
| IL (1) | IL314995A (https=) |
| MX (1) | MX2024009969A (https=) |
| TW (1) | TW202400223A (https=) |
| WO (1) | WO2023156385A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025228877A1 (en) | 2024-04-29 | 2025-11-06 | Merz Therapeutics GmbH | Botulinum toxin for the preventive treatment of migraine |
| WO2026021713A1 (en) | 2024-07-23 | 2026-01-29 | Merz Therapeutics GmbH | Uses of magnetic nerve stimulation associated with botulinum neurotoxin administration |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06192118A (ja) * | 1992-09-28 | 1994-07-12 | Wisconsin Alumni Res Found | ボツリヌス毒素を含む異常に過敏な筋運動障害の治療用薬剤組成物およびその製造方法 |
| US7037680B2 (en) * | 1993-09-21 | 2006-05-02 | The United States Of America As Represented By The Secretary Of The Army | Recombinant light chains of botulinum neurotoxins and light chain fusion proteins for use in research and clinical therapy |
| AU4746096A (en) * | 1995-06-06 | 1996-12-24 | Wisconsin Alumni Research Foundation | Analogs of botulinum toxin and pharmaceutical compositions o f botulinum toxin |
| PT2271670E (pt) | 2008-03-14 | 2014-11-28 | Allergan Inc | Ensaio imunobaseado da atividade do serotipo a da toxina botulínica |
| ES2653249T3 (es) | 2011-09-29 | 2018-02-06 | Cellsnap, Llc | Composiciones y métodos para ensayos de toxigenicidad |
| AU2014301116B2 (en) | 2013-06-28 | 2019-11-14 | Merz Pharma Gmbh & Co. Kgaa | Means and methods for the determination of the biological activity of Neurotoxin polypeptides in cells |
| WO2017188618A1 (en) * | 2016-04-26 | 2017-11-02 | Korea Prime Pharm Co., Ltd. | A novel composition comprising botulinum toxin |
| CA3060669A1 (en) * | 2017-04-28 | 2018-11-01 | Bonti, Inc. | Botulinum neurotoxins production methods |
| MX2021014486A (es) * | 2020-03-31 | 2022-01-04 | Obi Pharma Inc | Complejo de la toxina tipo a de clostridium botulinum, formulacion y uso del mismo. |
-
2023
- 2023-02-14 EP EP23704173.6A patent/EP4479012A1/en active Pending
- 2023-02-14 WO PCT/EP2023/053634 patent/WO2023156385A1/en not_active Ceased
- 2023-02-14 US US18/838,546 patent/US20250161186A1/en active Pending
- 2023-02-14 CA CA3243198A patent/CA3243198A1/en active Pending
- 2023-02-14 AR ARP230100337A patent/AR128515A1/es unknown
- 2023-02-14 IL IL314995A patent/IL314995A/en unknown
- 2023-02-14 JP JP2024547665A patent/JP2025504247A/ja active Pending
- 2023-02-14 AU AU2023222384A patent/AU2023222384A1/en active Pending
- 2023-02-14 MX MX2024009969A patent/MX2024009969A/es unknown
- 2023-02-14 KR KR1020247030631A patent/KR20240150786A/ko active Pending
- 2023-02-14 TW TW112105173A patent/TW202400223A/zh unknown
- 2023-02-14 CN CN202380022129.XA patent/CN118829442A/zh active Pending
-
2024
- 2024-08-12 CO CONC2024/0010938A patent/CO2024010938A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025504247A5 (https=) | ||
| US8952065B2 (en) | Acetylcysteine composition and uses thereof | |
| Komara et al. | Brain iron delocalization and lipid peroxidation following cardiac arrest | |
| JP2022530050A5 (https=) | ||
| JP2025504249A5 (https=) | ||
| SK7795A3 (en) | Bioactive compositions, preparation and use thereof | |
| JPS6289646A (ja) | 塩基性アミノ酸と脂肪酸の複合体及びその複合体からなる化粧品用添加剤 | |
| JPH08231335A (ja) | 含水化粧料の変臭・変色防止方法 | |
| RU2024120628A (ru) | Жидкий состав ботулинического токсина и его применение | |
| JP2024509907A5 (https=) | ||
| JP2942412B2 (ja) | 化粧料 | |
| JP3774735B2 (ja) | 洗浄剤組成物 | |
| RU2080871C1 (ru) | Средство, обладающее регенеративной активностью | |
| AU2011202871B2 (en) | Acetylcysteine composition and uses therefor | |
| JPH10175844A (ja) | デスモソームの分解促進剤 | |
| JPH0233013B2 (ja) | Sokonchiryozai | |
| RU2024120804A (ru) | Жидкий состав ботулинического токсина и его применение | |
| JPS6127908A (ja) | 肌荒れ防止剤 | |
| JP3434635B2 (ja) | 含水化粧料の変臭・変色防止方法 | |
| JPH0688891B2 (ja) | 養毛皮膚化粧料 | |
| JPH0348627A (ja) | カルシトニン腟坐剤 | |
| JP2003219815A (ja) | 緩衝液からなるローヤルゼリーの鮮度保持剤 | |
| HK40116988A (zh) | 液体肉毒杆菌毒素制剂及其用途 | |
| JP2002199849A (ja) | プロテアーゼ阻害剤を含有するローヤルゼリー組成物 | |
| RU2005141499A (ru) | Азотсодержащие гетероарильные соединения и их применение при повышении эндогенного эритропоэтина |